NEWS & INSIGHTS

View UPS Shipping Detail

Attention Clients:  Important change in implementation date for revisions to HHS and DOT workplace drug testing programs.

SAMHSA has postponed the May 1, 2010 implementation of the revised HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs.  The new effective date is October 1, 2010.

The delay was issued to provide sufficient time for the DOT to evaluate comments and issue a final rule harmonizing its regulations with the revised HHS Guidelines in a time frame that will permit implementation of the rules at the same time.  This action is welcomed; it will allow HHS-certified laboratories to use the same testing and reporting procedures for Federal workplace and transportation workplace drug testing programs subject to DOT Regulations, avoid the confusion of administering regulatory programs with different requirements and will ensure fairness in treatment of employees subject to the rules.  

A notice is posted in the Federal Register for publication on April 30, 2010.  The document is available at the Federal Register’s website:  Click Here

Workplace Drug Testing Updates

VERDICT®-II + LFAS

Print
Homepage  >  Testing Devices >  Criminal Justice & Rehabilitation Devices  >  Cassette Device with Adulterant Options  >  VERDICT®-II + LFAS

Description


VERDICT®-II devices were added to the MEDTOX line of on-site drug testing products to meet the needs of the criminal justice and treatment market with the federally recommended (SAMHSA) cut-off levels. VERDICT®-II devices are FDA 510(k)-cleared, single-step, immunoassay tests for the qualitative detection of drugs in urine. These devices utilize colloidal gold as the detection system in a competitive binding process. VERDICT®-II devices are simple to run, easy to interpret and deliver quick, efficient test results.

MEDTOX has stringent internal quality control/quality assurance procedures as part of our manufacturing process. In addition, all VERDICT®-II devices have an internal procedural control line which, when present, indicates that the sample has flowed up the strip correctly.

  • Available in 4-panel and 5-panel
  • Manufactured by an FDA registered, ISO certified facility that is backed by a SAMHSA certified laboratory
  • 510(k)-cleared
  • Made in the USA
  • The Lateral Flow (LatFlo®) Adulterant Strip (LFAS) is included onboard each device
  • Legally defensible
  • Technical support
  • Accurate and quick test results

Contact MEDTOX for detailed instructions.

MEDTOX
© 2008 MEDTOX Scientific, Inc. All rights reserved.